These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 23025997
1. Modifications around the hydroxamic acid chelating group of fosmidomycin, an inhibitor of the metalloenzyme 1-deoxyxylulose 5-phosphate reductoisomerase (DXR). Zinglé C, Kuntz L, Tritsch D, Grosdemange-Billiard C, Rohmer M. Bioorg Med Chem Lett; 2012 Nov 01; 22(21):6563-7. PubMed ID: 23025997 [Abstract] [Full Text] [Related]
5. A fragment-based approach to understanding inhibition of 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Mercklé L, de Andrés-Gómez A, Dick B, Cox RJ, Godfrey CR. Chembiochem; 2005 Oct 01; 6(10):1866-74. PubMed ID: 16116659 [Abstract] [Full Text] [Related]
9. Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosis. Andaloussi M, Lindh M, Björkelid C, Suresh S, Wieckowska A, Iyer H, Karlén A, Larhed M. Bioorg Med Chem Lett; 2011 Sep 15; 21(18):5403-7. PubMed ID: 21824775 [Abstract] [Full Text] [Related]
10. Synthesis and biological evaluation of phosphate isosters of fosmidomycin and analogs as inhibitors of Escherichia coli and Mycobacterium smegmatis 1-deoxyxylulose 5-phosphate reductoisomerases. Munier M, Tritsch D, Krebs F, Esque J, Hemmerlin A, Rohmer M, Stote RH, Grosdemange-Billiard C. Bioorg Med Chem; 2017 Jan 15; 25(2):684-689. PubMed ID: 27955925 [Abstract] [Full Text] [Related]
11. The crystal structure of E.coli 1-deoxy-D-xylulose-5-phosphate reductoisomerase in a ternary complex with the antimalarial compound fosmidomycin and NADPH reveals a tight-binding closed enzyme conformation. Mac Sweeney A, Lange R, Fernandes RP, Schulz H, Dale GE, Douangamath A, Proteau PJ, Oefner C. J Mol Biol; 2005 Jan 07; 345(1):115-27. PubMed ID: 15567415 [Abstract] [Full Text] [Related]
13. Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Chofor R, Sooriyaarachchi S, Risseeuw MD, Bergfors T, Pouyez J, Johny C, Haymond A, Everaert A, Dowd CS, Maes L, Coenye T, Alex A, Couch RD, Jones TA, Wouters J, Mowbray SL, Van Calenbergh S. J Med Chem; 2015 Apr 09; 58(7):2988-3001. PubMed ID: 25781377 [Abstract] [Full Text] [Related]
14. Isoprenoid biosynthesis as a target for antibacterial and antiparasitic drugs: phosphonohydroxamic acids as inhibitors of deoxyxylulose phosphate reducto-isomerase. Kuntz L, Tritsch D, Grosdemange-Billiard C, Hemmerlin A, Willem A, Bach TJ, Rohmer M. Biochem J; 2005 Feb 15; 386(Pt 1):127-35. PubMed ID: 15473867 [Abstract] [Full Text] [Related]
15. A high-throughput screening assay for simultaneous selection of inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose-5-phosphate synthase (Dxs) or 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr). Humnabadkar V, Jha RK, Ghatnekar N, De Sousa SM. J Biomol Screen; 2011 Mar 15; 16(3):303-12. PubMed ID: 21335601 [Abstract] [Full Text] [Related]